Thursday, April 7, 2016

BRIEF-Novartis' Sandoz unit receives EC approval for biosimilar Binocrit's nephrology indication

* Sandoz receives EC approval for subcutaneous route of administration in biosimilar Binocrit's nephrology indication











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)